Elevated ApoE, ApoJ and lipoprotein-bound α-synuclein levels in cerebrospinal fluid from Parkinson's disease patients – Validation in the BioFIND cohort-Reference-Cited by-同舟云学术

Elevated ApoE, ApoJ and lipoprotein-bound α-synuclein levels in cerebrospinal fluid from Parkinson's disease patients – Validation in the BioFIND cohort

Published:2023-11 Issue: Volume:116 Page:105765
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Paslawski Wojciech^ORCID,Svenningsson Per^ORCID

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference34 articles.

1. MDS clinical diagnostic criteria for Parkinson's disease;Postuma;Mov. Disord.,2015

2. Genetically-directed, cell type-specific sparse labeling for the analysis of neuronal morphology;Rotolo;PLoS One,2008

3. Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis;Gao;Int. J. Neurosci.,2015

4. Comparative study of cerebrospinal fluid alpha-synuclein seeding aggregation assays for diagnosis of Parkinson's disease;Kang;Mov. Disord.,2019

5. alpha-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients;Paslawski;Proc. Natl. Acad. Sci. U. S. A.,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic profiling reveals circulating biomarkers associated with incident and prevalent Parkinson’s disease;npj Parkinson's Disease;2024-07-09

2. Lipoproteins and α-synuclein in cerebrospinal fluid in Parkinson's disease: “Dangerous liaisons” on the road to neurodegeneration?;Parkinsonism & Related Disorders;2023-11